The Uromigos

Episode 61: Nick James discusses the latest update of the STAMPEDE study 21.09.2020 17:16 ↓

Nick gives us a quick summary of the STAMPEDE study and gives an overview of the latest data. 

Episode 60: Cora Sternberg discusses AMG 160 - a bispecific antibody in prostate cancer 21.09.2020 14:58 ↓

AMG 160; a half-life extended (HLE) bispecific T-cell engager (BITE®) antibody construct is discussed as is the future of immune therapy in CRPC. 

Episode 59: Ipatercertib in biomarker positive castrate resistant prostate cancer 20.09.2020 25:33 ↓

Chris Sweeney (last author) discusses the ATK inhibitor Ipatercertib in pTEN altered CRPC. A positive R3 trial in the ESMO plenary session. 

Episode 58: Brilliant ESMO discussant Richard Cathomas talks to Brian and Tom about the meaning of DANUBE and KN362 19.09.2020 26:44 ↓

The group go into the detail of chemo immune combinations and what to do next. 

Episode 57: Toni Choueiri - cabo & nivo vs sunitinib in metastatic clear cell renal cancer 19.09.2020 26:12 ↓

The group attempts to put the data into context with the other available combinations.

Episode 56: Matt Galsky and Tom Powles discuss ESMO 2020 immune therapy data in bladder cancer 19.09.2020 27:40 ↓

The group try to get to the bottom of whether these data has made any difference in treatment and future plans. 

Episode 55: The Uromigos Paper of the Month - Cabozantinib in Bladder Cancer by Dr. Andrea Apolo 31.08.2020 23:26 ↓

Andrea talks about her phase 2 trial which shows activity for Cabozantinib in urothelial cancer. 

Episode 54: Biomarkers in prostate cancer with Chris Sweeney 24.07.2020 25:05 ↓

Some thought it would never come - the final podcast of the World Tour from Boston.

Episode 53: Still in Boston - biomarkers in bladder cancer 24.07.2020 18:43 ↓

Tom, Brian and Chris Sweeney discuss the challenges of development of biomarkers for immune therapy in bladder cancer. 

Episode 52: The Final Stop - Boston: David McDermott discusses biomarkers in renal cancer in the era of immune therapy 24.07.2020 20:01 ↓

Tom, David and Brian discuss biomarkers in renal cancer in the era of immune therapy.

Episode 51: The Uromigos World Tour is in Norway with Jan Oldenburg - discussing key topics in testis cancer 18.07.2020 22:52 ↓

Jan Oldenburg from Norway discusses treatment choices for stage 1 testis cancer, the dilemma of high dose therapy for relapse and long term toxicity of chemotherapy. 

Episode 50: The Uromigos World Tour in London with renal cancer surgery 15.07.2020 22:53 ↓

Axel Bex talks about small renal masses, robotic vs partial nephrectomy and surgery in metastatic disease. 

Episode 49: The Tour remains in Germany with Oliver Grimm and renal cancer 14.07.2020 22:15 ↓

The World Tour stays in Germany to discuss the first line renal cancer (clear cell and non-clear cell) and clinical trials with Oliver Grimm. 

Episode 48: ...and then Germany - Jürgen Gschwend discusses cystectomy for urothelial cancer 10.07.2020 20:38 ↓

Jürgen discusses German research and surgery for bladder cancer. The podcast ends abruptly - which was not his fault! 

Episode 46: The Uromigos World Tour in Spain discussing SOGUG and Renal Cancer with Cristina Suarez 09.07.2020 19:38 ↓

Cristina Suarez discusses the success of clinical trials in Spain, and access to treatments. 

Episode 45: The Uromigos World Tour arrives in Japan 03.07.2020 20:29 ↓

Yoshi Tomita explains treatment pathways and research in GU cancer in Japan. Brian explains why he likes Japan so much. 

Episode 44: The Uromigos World Tour in Australia - Talking with Ian Davis about prostate cancer and ANZUP 03.07.2020 31:51 ↓

Ian Davis discusses why ANZUP has been so successful, and the EnzaMet study. An uninvited guest arrives towards the end. 

Episode 43: The Uromigos World Tour in Singapore with Ravi Kanesvaran 29.06.2020 18:20 ↓

Ravi describes treatment pathways and research for Southeast Asia in GU cancer. 

Episode 42: The Uromigos in Argentina 28.06.2020 12:08 ↓

Juan Sade discusses research, treatment pathways in GU cancer, steak and red wine in Argentina. 

Episode 41: The Uromigos World Tour lands in Brazil - Fernando Maluf talks about prostate cancer and recent research in Brazil 25.06.2020 24:04 ↓

The tour lands in sunny Brazil with a trip to a Japanese restaurant and a discussion about research and prostate cancer. 

Episode 40: The Uromigos World Tour moves to France - Bernard Escudier discusses 2nd line therapy in renal cancer and Tivozanib 22.06.2020 20:02 ↓

The Uromigos World Tour moves to Paris. Treatment for tumours that progress after first line immunetherapy is discussed. The role of Tivozanib is a focus for the dialogue. 

Episode 39: The Uromigos World Tour - Renal Cancer and IMDC Risk with Danny Heng in Calgary 18.06.2020 20:17 ↓

Danny discusses Italian food and the past, present and future of the IMDC prognostic score. 

Episode 38: The Uromigos Virtual World Tour - starting in Vancouver with Atezolizumab in NMIBC 16.06.2020 20:21 ↓

Peter Black talks about his recent BCG refractory NMIBC ASCO presentation and its implications for the field. 

Episode 37: Regoratinib (FGFR inhibitor) and Atezolizumab in UC with Jonathan Rosenberg 01.06.2020 18:11 ↓

Everything you wanted to know about FGFR inhibition but were afraid to ask. 

Episode 36: Dr. Tian Zhang discusses three ASCO bladder cancer abstracts with immune therapy/targeted therapy combinations 01.06.2020 20:58 ↓

 Tian Zhang discusses three ASCO bladder cancer abstracts with immune therapy/targeted therapy combinations